Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Cerebral Small Vessel Disease
NCT06301711Not yet recruiting
- Sponsor
- Ahmadu Bello University Teaching Hospital
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of lidocaine in Cerebral Small Vessel Disease (CSVD) (2 arms), sponsored by Ahmadu Bello University Teaching Hospital. Primary endpoint: Penetration-Aspiration Scale at day 10. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT06301711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301711.